A Randomized Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering a Daily Dose of 2500 μg of Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel 1.5mg Oral Dose on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Ulipristal (Primary) ; Levonorgestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- 11 Aug 2017 Planned End Date changed from 1 Dec 2016 to 31 Dec 2017.
- 11 Aug 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
- 11 Aug 2017 Status changed from recruiting to active, no longer recruiting.